Form 4: Itron Director Jerome Lande Receives Stock Grant
Director Stock Grant Disclosure
Director Jerome J. Lande acquired 580 shares of Itron, Inc. common stock as part of his quarterly board compensation.
Summary
- Director Jerome J. Lande was granted 580 shares of Itron, Inc. (ITRI) common stock on April 1, 2026.
- The shares were issued as part of the standard quarterly compensation for independent members of the board of directors.
- Following this transaction, the director's total beneficial ownership increased to 10,144 shares.
- The shares were acquired at no cost ($0 price) as part of the company's equity compensation program.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that has no material impact on the company's financial outlook.
Positives
- The transaction reflects standard equity-based compensation for board members, aligning director interests with long-term shareholder value.
Negatives
- None.
Risks
- None.
Future Outlook
Not applicable as this is a routine disclosure of director compensation.
Management Comments
- The grant reflects the common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service.
Industry Context
StockSavvy.ai notes that routine equity grants to board members are standard corporate governance practices designed to ensure director alignment with company performance and shareholder interests.
Comparison to Industry Standards
- The issuance of equity as part of director compensation is a standard practice among S&P 400 and technology-sector companies to incentivize long-term oversight.
- The transaction size and nature are consistent with typical quarterly director compensation packages for mid-cap technology firms.
Stakeholder Impact
- Minimal impact on shareholders as this is a standard, pre-planned component of director compensation.
Next Steps
- None.
Key Dates
| Date | Description |
|---|---|
| 04/01/2026 | Date of the stock grant transaction. |
| 04/02/2026 | Date of filing the Form 4. |
Keywords
Itron, ITRI, Form 4, Insider Trading, Director Compensation, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.